关注
Fatih Gürler
Fatih Gürler
Gazi University School of Medicine
在 gazi.edu.tr 的电子邮件经过验证
标题
引用次数
引用次数
年份
A prognostic parameter in advanced non-small cell lung cancer: the ratio of hemoglobin-to-red cell distribution width
Y Bozkaya, B Kurt, F Gürler
International journal of clinical oncology 24, 798-806, 2019
432019
Geoepidemiology and clinical characteristics of neonatal lupus erythematosus: asystematic literature review of individual patients' data
A Erden, A Fanouriakis, L Kiliç, A Sari, B Armağan, E Bilgin, YZ Şener, ...
Turkish Journal of Medical Sciences 50 (2), 281-290, 2020
172020
Sinonasal SMARCB1 (INI1) deficient carcinoma with yolk sac tumor differentiation: a case report and treatment options
B Hazir, B Şímșek, A Erdemír, F Gürler, O Yazici, Y Kizil, U Aydíl
Head and Neck Pathology 16 (2), 596-601, 2022
142022
The relationship between hemoglobin-RDW ratio and clinical outcomes in patients with advanced pancreas cancer.
A İLhan, F Gurler, F Yilmaz, E Eraslan, M Dogan
European Review for Medical & Pharmacological Sciences 27 (5), 2023
102023
Does docetaxel matter in metastatic gastric cancer? FOLFOX versus FLOT regimens as first-line treatment
F Gürler, A İlhan, DC Güven, O Turhan, BK İnci, O Sütçüoğlu, F Yildiz, ...
Anti-cancer drugs 33 (1), e477-e485, 2022
72022
Retrospective comparison of flot and modified dcf as first-line chemotherapy in metastatic gastric adenocarcinoma
F Gürler, DC Güven, E Aydemir, O Sütçüoğlu, BK Inci, Z Arik, Ş Yalçin, ...
Turkish Journal of Medical Sciences 52 (5), 1559-1568, 2022
42022
Current status of biosimilars in Turkey: a survey among medical oncologists
F Gürler, DD Kasım, B Kurt İnci, O Sütçüoğlu, O Ünsal, V Aslan, G Tahtacı, ...
Journal of Oncology Pharmacy Practice 28 (7), 1516-1523, 2022
32022
Pandemi Sürecinde Kanser Tanı, Tedavi, Takibinde Karşılaşılacak Sorunlar ve Muhtemel Değişiklikler
AÖ Bediz KURT İNCİ, Fatih GÜRLER
Kanser ve Covid-19 Pandemisi Özel Sayısı 1, p.69-73, 2020
3*2020
SAT0567 Demographic, Clinic and Laboratory Features of 755 Patients with Neonatal Lupus Erythematosus: Systematic Review
A Erden, L Kilic, E Bilgin, S Ceylan, B Hymabaccus, YZ Sener, F Gürler, ...
Annals of the Rheumatic Diseases 75 (Suppl 2), 874-874, 2016
22016
Prognostic significance of nadir PSA value and time to nadir PSA in patients with metastatic castration-naive prostate cancer receiving first-line hormonotherapy
BK İnci, F Gürler, O Sütcüoğlu, V Baştuğ, A Üner, A Özet, N Özdemir
Journal of cancer research and therapeutics 19 (Suppl 2), S845-S850, 2023
12023
Tam Kan Sayımı Parametreleri ile İleri Evre Mide Kanseri Olan Hastaların Prognozunu Tahmin Edilebilir Mi?
O Sütçüoğlu, A Fincan, F Gürler, BK İnci, NY Özdemir
Turkish Journal of Clinics and Laboratory 14 (2), 243-245, 2023
12023
How long does crizotinib work? a rare case of recurrent inflammatory myofibroblastic tumor
HC Albayrak, F Gürler, O Sütçüoğlu, N Akyürek, A Özet
Anti-cancer drugs 33 (1), 109-111, 2022
12022
The role of serum albumin/globulin ratio in combination with prognostic risk indexes of febrile neutropenia
O Sütcüoğlu, O Akdoğan, F Gürler, B Kurt İnci, N Özdemir, A Özet, ...
International Journal of Clinical Practice 75 (7), e14185, 2021
12021
Effect of serum uric acid level and Multinational Association for Supportive Care in Cancer risk score on febrile neutropenia mortality
O Sütcüoğlu, O Akdoğan, BK İnci, F Gürler, N Özdemir, O Yazıcı
Supportive Care in Cancer 29, 1047-1053, 2021
12021
The prognostic value of tumor/lymph node standardized uptake value max ratio and correlation with hematologic parameters in stage III nonsmall cell lung cancer
Y Açikgoz, F Gurler, BK Inci, Y Ergun, G Ucar, M Dirikoc, SA Esen, ...
Medicine 99 (48), e23168, 2020
12020
1473P Parameters of complete blood count might predict the prognosis of patients with advanced gastric cancer
O Sutcuoglu, A Fincan, F Gürler, BK Inci, NÖ Yıldırım
Annals of Oncology 31, S919-S920, 2020
12020
Anti-Ro/La ilişkili konjenital kalp bloğunda prednisolonun uygunsuz kullanımı ve tedavi protokollerindeki heterojenite: 492 vakanın gözden geçirilmesi.
A Erden, L Kılıç, A Sarı, B Armağan, E Bilgin, S Ceylan, YZ Şener, ...
Journal of Turkish Society for Rheumatology 11 (1), 2019
12019
The impact of the expression level of growth differentiation factor 15 in tumor tissue on the response to immunotherapy in non-small cell lung cancer
O Akdogan, B Ogut, O Sutcuoglu, A Sert, F Gurler, N Akyurek, N Ozdemir, ...
BMC cancer 24 (1), 1-9, 2024
2024
Comparison of the second-line treatment efficacy in advanced gastric cancer patients previously treated with taxane-based triplet chemotherapy: a Turkish Oncology Group Study
K Bir Yücel, M Uğraklı, S Sekmek, N Yıldırım, F Gürler, O Yazıcı, A Özet, ...
Current Medical Research and Opinion 40 (7), 1137-1143, 2024
2024
A propensity score‐matched comparison of neoadjuvant chemoradiotherapy with cisplatin‐5FU and carboplatin–paclitaxel in locally advanced esophageal squamous cell carcinoma: A …
F Gürler, F Tay, Z Sucuoğlu İşleyen, T Yerlikaya, E Hendem, SA Esen, ...
Cancer Medicine 13 (14), e70002, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20